Juang, Duane S.
Juang, Terry D.
Dudley, Dawn M.
Newman, Christina M.
Accola, Molly A.
Rehrauer, William M.
Friedrich, Thomas C. http://orcid.org/0000-0001-9831-6895
O’Connor, David H. http://orcid.org/0000-0003-2139-470X
Beebe, David J. http://orcid.org/0000-0002-0415-9006
Funding for this research was provided by:
Wisconsin Alumni Research Foundation (COVID-19 Accelerator Challenge Award)
U.S. Department of Health & Human Services | National Institutes of Health (NIH P30CA014520, NIH 1R01CA247479, NIH 1R01CA247479-01, NIH 5UL1TR002373-03, NIH OD011106)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 30 September 2020
Accepted: 10 June 2021
First Online: 14 July 2021
Competing interests
: The authors declare the following competing interests. David J. Beebe holds equity in Bellbrook Labs LLC, Tasso Inc., Salus Discovery LLC, Lynx Biosciences Inc., Stacks to the Future LLC, Turba LLC, Onexio Biosystems LLC, and Flambeau Diagnostics LLC. David J. Beebe is also a consultant for Abbott Laboratories. Duane S. Juang holds equity in Turba LLC. A patent application (16/894273) of which D.J.B., D.S.J., T.D.J., D.H.O., and T.C.F. are inventors was filed through the Wisconsin Alumni Research Foundation for the OIL-TAS technology described in this work. All other authors declare no competing interests.